The IMA (Investment Management Association) commissioned CRA to undertake an independent appraisal of both the potential impact of the FSA’s proposals set out in CP1761 and the cost-benefit analysis undertaken for the FSA by OXERA2. In particular, CRA was asked to examine in more detail: how these proposals might be implemented in practice; how the detail of their rules could affect the market outcome; and whether there were alternative proposals also worthy of further consideration.
DOJ declinations show the value of early voluntary disclosure
US Department of Justice (DOJ) declinations involving Robert Bosch GmbH (Bosch) and Campus Eye Management Holdings LLC (Campus Eye) offer early insight into...